Key opinion leaders provide their final thoughts on treatment management for patients with MDS. Ryan Haumschild, PharmD, MS, MBA: Thank you for this rich and informative discussion. Before we conclude ...
Drs Zeidan and Fazal share their opinions on setting appropriate goals for treatment of patients with MDS. Ryan Haumschild, PharmD, MS, MBA: Let’s talk a little more about the management of ...
Deep in the bone marrow lies the reason for blood disorders classified as myelodysplastic syndromes—stem cells gone awry. In the mid-1970s, a group of pathologists and clinicians from around the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback